Inspecs GroupINPEF 52 Gross Margin % is 51.67% as of Dec. 2025, which is 12% above its 10-year median of 46.09. GuruFocus rates INPEF with a GF Score™ of 52/100 and a GF Value™ of $0.65. The stock has 6 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Inspecs Group ranks worse than 50.68% on this metric.
The historical rank and industry rank for Inspecs Group's Gross Margin % or its related term are showing as below:
INPEF'
s Gross Margin % Range Over the Past 10 Years
Min: 39 Med: 46.09 Max: 52.44
Current: 51.74
During the past 10 years, the highestGross Margin % of Inspecs Group was 52.44%. The lowest was 39.00%. And the median was 46.09%.
INPEF's Gross Margin % is ranked worse than 50.68% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs INPEF: 51.74
Inspecs Group had a gross margin of 51.67% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Inspecs Group was 3.70% per year.
Inspecs Group (OTCPK:INPEF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Inspecs Group had a gross margin of 51.67% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Inspecs Group Gross Margin % Related Terms
Inspecs Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for Inspecs Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INPEF vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Inspecs Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspecs Group Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspecs Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Inspecs Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Inspecs Group (INPEF) has a Gross Margin % of 51.67% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Inspecs Group and its competitors. This is 12% above median its historical median of 46.09. Over the past decade, Inspecs Group's Gross Margin % has ranged from 39.00 to 52.44. According to the industry distribution chart, Inspecs Group ranks #408 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 50.7%.
Is Inspecs Group's Gross Margin % too high?
Inspecs Group's current Gross Margin % of 51.67% is 12% above median its 10-year median of 46.09. Over the past 10 years, this metric has ranged from a low of 39.00 to a high of 52.44. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Inspecs Group's value of 51.67% is 0.8% below this industry median. Based on the distribution chart, Inspecs Group ranks #408 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Inspecs Group has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Inspecs Group's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Inspecs Group ranks #408 out of 805 companies for Gross Margin %. This places Inspecs Group in the lower half of its industry. The industry median Gross Margin % is 52.07. Inspecs Group's value of 51.67% is 0.8% below this benchmark. Historically, Inspecs Group's own Gross Margin % has ranged from 39.00 to 52.44 over the past decade. While the company's 10-year median is 46.09 vs. the industry median of 52.07, Inspecs Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inspecs Group's current Gross Margin % of 51.67% is 0.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Inspecs Group and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspecs Group's current Gross Margin % is 51.67%, which is 12% above median its own 10-year median of 46.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspecs Group stock overvalued right now?
Inspecs Group (INPEF) has a current Gross Margin % of 51.67%. The stock's GF Value™ is $0.65, compared to a current price of $1.08 — trading 66.2% above its estimated fair value. The current Gross Margin % is 51.67%, which is 12% above median its 10-year median of 46.09 and 0.8% below the Medical Devices & Instruments industry median of 52.07. Inspecs Group's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Inspecs Group (INPEF), the current Gross Margin % is 51.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspecs Group (INPEF) Overvalued in 2026?
Based on GuruFocus' analysis, Inspecs Group stock appears to be overvalued.
The current stock price of $1.08 is trading 66.2% above its estimated GF Value™ of $0.65.
Key valuation signals for INPEF:
Gross Margin %: 51.67% (12% above median its 10-year median of 46.09)
GF Value™: $0.65 vs. price of $1.08 (66.2% above fair value)
Industry Position: 0.8% below the Medical Devices & Instruments median (#408 of 805)
No single metric tells the full story. See the INPEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspecs Group PLC is a designer and manufacturer of eyewear frames and accessories. The customers of the company include optical and Non-optical retailers, distributors, and independent opticians. The company operations are spread across the United Kingdom, Europe (excluding the UK), South America, North America, Asia, Africa, and Australia. Its eyewear brands include Superdry, Titanflex, O'Neill, Brendel, Humphreys, Marc O'Polo, and among others. The reporting segments of the company are Frames and Optics product distribution which derives maximum revenue, and Manufacturing includes OEM and manufacturing distribution segment.
52GF Score
Get the complete analysis for INPEF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INPEF has been successfully added to your 
